(KWR) Quaker Chemical - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 2.416m USD | Total Return: 35.1% in 12m
Avg Turnover: 20.2M
EPS Trend: -45.9%
Qual. Beats: 0
Rev. Trend: -59.3%
Qual. Beats: 1
Warnings
P/E ratio 535.1
Tailwinds
No distinct edge detected
Quaker Chemical Corporation, operating as Quaker Houghton, is a global provider of formulated specialty chemicals and chemical management services. The company’s portfolio includes process fluids such as metal removal lubricants, corrosion inhibitors, and hydraulic fluids tailored for heavy industrial applications. Key end markets include the steel, aluminum, automotive, aerospace, and mining sectors.
The specialty chemicals sector is characterized by high switching costs due to the critical role these fluids play in maintaining equipment integrity and manufacturing precision. Quaker Houghton operates under a high-touch business model, often embedding technical personnel within client facilities to optimize fluid performance and reduce waste. Investors can evaluate these operational efficiencies and margin trends further on ValueRay.
Founded in 1918 and headquartered in Conshohocken, Pennsylvania, the company maintains a diverse geographic footprint to support global manufacturing supply chains. Its integration of chemical products with on-site management services creates a recurring revenue stream tied to industrial production volumes rather than one-time capital expenditures.
- Steel and aluminum production volumes dictate global industrial fluid demand
- Raw material cost fluctuations impact specialty chemical gross profit margins
- Automotive manufacturing shifts toward electric vehicles alter metalworking fluid requirements
- Global manufacturing PMI trends drive cyclical revenue performance across heavy industry
- Chemical management service contracts provide recurring revenue and customer retention stability
| Net Income: 4.26m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: 29.29% < 20% (prev 29.77%; Δ -0.48% < -1%) |
| CFO/TA 0.05 > 3% & CFO 143.3m > Net Income 4.26m |
| Net Debt (761.8m) to EBITDA (175.7m): 4.34 < 3 |
| Current Ratio: 2.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.4m) vs 12m ago -1.87% < -2% |
| Gross Margin: 34.38% > 18% (prev 0.37%; Δ 3.40k% > 0.5%) |
| Asset Turnover: 70.47% > 50% (prev 68.04%; Δ 2.44% > 0%) |
| Interest Coverage Ratio: 1.66 > 6 (EBITDA TTM 175.7m / Interest Expense TTM 46.8m) |
| A: 0.20 (Total Current Assets 952.6m - Total Current Liabilities 388.5m) / Total Assets 2.80b |
| B: 0.22 (Retained Earnings 607.5m / Total Assets 2.80b) |
| C: 0.03 (EBIT TTM 77.4m / Avg Total Assets 2.73b) |
| D: 0.35 (Book Value of Equity 499.5m / Total Liabilities 1.42b) |
| Altman-Z'' = 2.59 = A |
| DSRI: 0.99 (Receivables 441.2m/418.7m, Revenue 1.93b/1.81b) |
| GMI: 1.07 (GM 34.38% / 36.72%) |
| AQI: 0.77 (AQ_t 0.43 / AQ_t-1 0.56) |
| SGI: 1.06 (Revenue 1.93b / 1.81b) |
| TATA: -0.05 (NI 4.26m - CFO 143.3m) / TA 2.80b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 139.13 with a total of 110,261 shares traded.
Over the past week, the price has changed by +2.79%,
over one month by +3.30%,
over three months by -16.22% and
over the past year by +35.06%.
Quaker Chemical has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy KWR.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 169.5 | 21.8% |
P/E Forward = 19.6078
P/S = 1.2544
P/B = 1.7711
P/EG = 1.8561
Revenue TTM = 1.93b USD
EBIT TTM = 77.4m USD
EBITDA TTM = 175.7m USD
Long Term Debt = 837.1m USD (from longTermDebt, last quarter)
Short Term Debt = 50.2m USD (from shortTermDebt, last quarter)
Debt = 931.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 22.1m
Net Debt = 761.8m USD (calculated: Debt 931.6m - CCE 169.7m)
Enterprise Value = 3.18b USD (2.42b + Debt 931.6m - CCE 169.7m)
Interest Coverage Ratio = 1.66 (Ebit TTM 77.4m / Interest Expense TTM 46.8m)
EV/FCF = 22.27x (Enterprise Value 3.18b / FCF TTM 142.7m)
FCF Yield = 4.49% (FCF TTM 142.7m / Enterprise Value 3.18b)
FCF Margin = 7.41% (FCF TTM 142.7m / Revenue TTM 1.93b)
Net Margin = 0.22% (Net Income TTM 4.26m / Revenue TTM 1.93b)
Gross Margin = 34.38% ((Revenue TTM 1.93b - Cost of Revenue TTM 1.26b) / Revenue TTM)
Gross Margin QoQ = 36.78% (prev 31.86%)
Tobins Q-Ratio = 1.13 (Enterprise Value 3.18b / Total Assets 2.80b)
Interest Expense / Debt = 5.02% (Interest Expense 46.8m / Debt 931.6m)
Taxrate = 26.57% (7.14m / 26.9m)
NOPAT = 56.9m (EBIT 77.4m * (1 - 26.57%))
Current Ratio = 2.45 (Total Current Assets 952.6m / Total Current Liabilities 388.5m)
Debt / Equity = 0.68 (Debt 931.6m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 4.34 (Net Debt 761.8m / EBITDA 175.7m)
Debt / FCF = 5.34 (Net Debt 761.8m / FCF TTM 142.7m)
Total Stockholder Equity = 1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.16% (Net Income 4.26m / Total Assets 2.80b)
RoE = 0.31% (Net Income TTM 4.26m / Total Stockholder Equity 1.36b)
RoCE = 3.52% (EBIT 77.4m / Capital Employed (Equity 1.36b + L.T.Debt 837.1m))
RoIC = 2.31% (NOPAT 56.9m / Invested Capital 2.46b)
WACC = 8.70% (E(2.42b)/V(3.35b) * Re(10.63%) + D(931.6m)/V(3.35b) * Rd(5.02%) * (1-Tc(0.27)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -75.02 | Cagr: -1.22%
[DCF] Terminal Value 73.59% ; FCFF base≈145.3m ; Y1≈140.6m ; Y5≈138.3m
[DCF] Fair Price = 74.08 (EV 2.05b - Net Debt 761.8m = Equity 1.29b / Shares 17.4m; r=8.70% [WACC]; 5y FCF grow -4.35% → 2.50% )
EPS Correlation: -45.91 | EPS CAGR: -3.42% | SUE: -0.26 | # QB: 0
Revenue Correlation: -59.30 | Revenue CAGR: -1.87% | SUE: 0.99 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.61 | Chg30d=-22.21% | Revisions=-50% | Analysts=6
EPS next Quarter (2026-09-30): EPS=1.97 | Chg30d=-12.18% | Revisions=-50% | Analysts=6
EPS current Year (2026-12-31): EPS=7.01 | Chg30d=-8.98% | Revisions=-50% | GrowthEPS=-0.1% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=8.77 | Chg30d=-5.71% | Revisions=-33% | GrowthEPS=+25.1% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: -50%